Water vapor or surgery? new study aims to protect ejaculation in prostate treatment

NCT ID NCT07648888

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two minimally invasive procedures for men with an enlarged prostate: water vapor thermal therapy (Rezum) and ejaculation-sparing surgery. It includes 120 sexually active men aged 50 or older who have moderate-to-severe urinary symptoms. The goal is to see which treatment better preserves ejaculation while improving urine flow over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Water vapor thermal therapy (Rezum) and ejaculation-sparing bipolar transurethral enucleation of the prostate (ES-B-TUEP)
What this could lead to
If successful, this could help doctors choose which procedure better preserves ejaculation while relieving urinary symptoms in men with an enlarged prostate.
What could go wrong
This is a small, non-randomized study, so results may not apply to all men. Both procedures carry risks like infection, bleeding, or urinary problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia Ejaculatory Dysfunction Lower Urinary Tract Symptoms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Urology- Beni-Suef University Hospitals

    RECRUITING

    Banī Suwayf, Beni Suweif Governorate, 02456, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.